Doxycycline – hope for syphilis and chlamydia prevention?

+Practice
In print
Sexual health

Doxycycline – hope for syphilis and chlamydia prevention?

By Massimo Giola
Sparklers
Doxycycline post-exposure prophylaxis may be cause for celebration for those at high risk of sexually transmitted infections [Image: Nina Hill on Unsplash]

Sexual health specialist Massimo Giola looks at the evidence for doxycycline post-exposure prophylaxis as a prevention tool for syphilis, chlamydia and gonorrhoea

Key points, Doxycycline post-exposure prophylaxis is emerging as a key tool for the control of syphilis and chlamydia epidemics among high-risk populations. The, Pract Green w Pale Yellow
References

1. Highleyman L. Sexually transmitted infections in San Francisco have fallen since doxyPEP roll-out. 5 March 2024.

2. Centers for Disease Control and Prevention. Guidelines for the use of doxycycline post-exposure prophylaxis for bacterial sexually transmitted infection prevention. October 2023.

3. Cornelisse VJ, Ong JJ, Ryder N, et al. Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand - the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Sex Health 2023;20(2):99–104.